Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss

Semaglutide

Triple-Dose Semaglutide Outperforms Standard Regimen in Weight-Loss Trials

Researchers say the 72-week studies showed greater weight loss with acceptable tolerability, warranting longer-term follow-up.

Half of Semaglutide Users Quit Within a Year as Higher Dose Trials Show Bigger Losses, More Side Effects